败血症中的蛋白质翻译后修饰:分子机制和生物标志物
Yuze Wang1, Hongyi Li1, Qian Zhao2
1General Intensive Care Medicine, Department of Emergency Medicine, The First Affiliated Hospital of Zhengzhou University, Henan Engineering Research Center for Critical Care Medicine, Henan Key Laboratory of Critical Care Medicine, Henan Key Laboratory of Sepsis in Health Commission, Zhengzhou Key Laboratory of Sepsis, Henan Sepsis Diagnosis and Treatment Center, Zhengzhou 450052, China.
Ageing research reviews
|December 4, 2025
概括
翻译后修改 (PTMs) 对于理解败血症至关重要,这是一个致命的疾病. 研究强调了PTMs.
科学领域:
- 分子生物学分子生物学
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
背景情况:
- 败血症是一种危及生命的疾病,具有复杂的病理生理学,使早期诊断具有挑战性.
- 了解分子机制对于识别败血症生物标志物和改善患者治疗结果至关重要.
研究的目的:
- 阐明在败血症中转化后修饰 (PTM) 的调节作用.
- 审查PTM相关的生物标志物用于败血症诊断,预后和器官功能障碍.
- 讨论研究败血症中PTM的方法.
主要方法:
- 文献综述,重点关注败血症途径中的PTM.
- 分析PTM在免疫反应,炎症,代谢重编程和内皮损伤中的作用.
- 关于基于PTM的败血症生物标志物的当前研究总结,重点是糖化.
主要成果:
- PTMs显著调节与败血症相关的关键途径,包括免疫反应和炎症.
- PTMs影响细胞代谢重编程和败血症中的内皮损伤.
- 葡萄糖化作为败血症生物标志物特别有前途.
结论:
- 在复杂的败血症病理生理学中,PTM发挥着关键的调节作用.
- 基于PTM的生物标志物为改善败血症诊断,预后和管理提供了潜力.
- 对PTM的进一步研究,特别是糖化,对于推进败血症治疗至关重要.
相关概念视频
Covalently Linked Protein Regulators
8.6K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.6K
Translational Regulation
508
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
508
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
763
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
763
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
521
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
521


